Related Experiment Video
Updated: May 7, 2026

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
Fluorescence Dynamics Imaging Reveals Inflammation Driven by Ferroptosis through a MAO/ONOO- Dual-Responsive Probe
Wenjiao Wu1, Huming Yan1, Le Zhang2
1Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Biomedical and Health Laboratory in Shanxi Province, Institute of Molecular Science, Shanxi University, Taiyuan 030006, China.
None:
Inflammation, as a critical defensive response of the body, can exacerbate tissue damage through oxidative cascade reactions when it becomes uncontrolled. Among the key oxidative stress mediators are monoamine oxidase A (MAO-A) and peroxynitrite (ONOO-), which synergistically promote cellular damage. To further elucidate their molecular mechanisms of action, precise and reliable imaging tools are required for spatiotemporal dynamic monitoring of both mediators. Addressing the limitations of traditional dual-probe detection, which suffers from inconsistencies in distribution and response, this study developed a mitochondria-targeted dual-responsive fluorescent probe, KMO, achieving the first in situ real-time visualization of MAO-A and ONOO- in inflammatory cells and an acute hepatitis mouse model. Utilizing this tool, we revealed a self-amplifying cycle in inflammation characterized by "MAO-A activation─ONOO- burst─ferroptosis─inflammation exacerbation", and demonstrated that inhibiting ferroptosis can disrupt this pathway. This work not only provides a fluorescent imaging tool but also establishes a theoretical and experimental foundation for elucidating the mechanisms of acute inflammation and targeted interventions.
More Related Videos
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024